TY - JOUR
T1 - The Enterics for Global Health (EFGH) Shigella Surveillance Study in Pakistan
AU - Ahmed, Naveed
AU - Yousafzai, Mohammad Tahir
AU - Qamar, Farah Naz
N1 - Publisher Copyright:
Published by Oxford University Press on behalf of Infectious Diseases Society of America 2024.
PY - 2024/3/1
Y1 - 2024/3/1
N2 - Background. The Enterics for Global Health (EFGH) Shigella surveillance study is a longitudinal multicountry study that aims to estimate incidence rates and document consequences of Shigella diarrhea within 7 countries in Africa, Asia, and Latin America. In addition to a high incidence of childhood diarrhea, Pakistan is facing a problem of antimicrobial resistance in urban and peri-urban areas of Karachi. Methods. In Pakistan, EFGH will be conducted in Karachi, which is one of the metropolitan cities bordering the Arabian Sea and has a diverse population of 1.6 million according to the 2017 population census. The study aims to enroll 1400 children aged 6–35 months over 2 years (2022–2024) from 6 health care facilities (Abbasi Shaheed Hospital, Khidmat-e-Alam Medical Centre, Sindh Government Hospital Korangi 5, Sindh Government Hospital Ibrahim Hyderi, Ali Akbar Shah VPT Center, and Bhains Colony VPT Center) situated in Nazimabad and Bin-Qasim town. Moreover, population enumeration and health care utilization surveys from a defined catchment area of health facilities will be conducted to estimate the Shigella diarrhea incidence rates. Conclusions. The study will provide critical data to policy-makers about the burden of Shigella and antimicrobial resistance, which is essential for planning Shigella vaccine trials.
AB - Background. The Enterics for Global Health (EFGH) Shigella surveillance study is a longitudinal multicountry study that aims to estimate incidence rates and document consequences of Shigella diarrhea within 7 countries in Africa, Asia, and Latin America. In addition to a high incidence of childhood diarrhea, Pakistan is facing a problem of antimicrobial resistance in urban and peri-urban areas of Karachi. Methods. In Pakistan, EFGH will be conducted in Karachi, which is one of the metropolitan cities bordering the Arabian Sea and has a diverse population of 1.6 million according to the 2017 population census. The study aims to enroll 1400 children aged 6–35 months over 2 years (2022–2024) from 6 health care facilities (Abbasi Shaheed Hospital, Khidmat-e-Alam Medical Centre, Sindh Government Hospital Korangi 5, Sindh Government Hospital Ibrahim Hyderi, Ali Akbar Shah VPT Center, and Bhains Colony VPT Center) situated in Nazimabad and Bin-Qasim town. Moreover, population enumeration and health care utilization surveys from a defined catchment area of health facilities will be conducted to estimate the Shigella diarrhea incidence rates. Conclusions. The study will provide critical data to policy-makers about the burden of Shigella and antimicrobial resistance, which is essential for planning Shigella vaccine trials.
KW - Karachi
KW - Pakistan
KW - Shigella
KW - surveillance
UR - http://www.scopus.com/inward/record.url?scp=85188811674&partnerID=8YFLogxK
U2 - 10.1093/ofid/ofad651
DO - 10.1093/ofid/ofad651
M3 - Article
AN - SCOPUS:85188811674
SN - 2328-8957
VL - 11
SP - S113-S120
JO - Open Forum Infectious Diseases
JF - Open Forum Infectious Diseases
IS - Supplement_1
ER -